AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 115 filers reported holding AKERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,766,000 | -32.9% | 617,727 | 0.0% | 8.75% | +25.2% |
| Q4 2021 | $13,065,000 | -5.4% | 617,727 | 0.0% | 6.99% | +22.3% |
| Q3 2021 | $13,806,000 | -9.9% | 617,727 | 0.0% | 5.72% | +12.6% |
| Q2 2021 | $15,326,000 | -14.5% | 617,727 | 0.0% | 5.08% | +45.5% |
| Q1 2021 | $17,920,000 | -10.7% | 617,727 | -20.6% | 3.49% | +67.5% |
| Q4 2020 | $20,065,000 | -16.2% | 777,727 | 0.0% | 2.08% | -52.5% |
| Q3 2020 | $23,946,000 | -100.0% | 777,727 | -63.2% | 4.38% | -42.1% |
| Q2 2020 | $52,717,114,000 | -9.1% | 2,115,454 | -22.7% | 7.57% | -52.4% |
| Q1 2020 | $58,015,326,000 | – | 2,736,572 | – | 15.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 103,816 | $5,251,013 | 6.02% |
| Boxer Capital, LLC | 1,676,733 | $84,809,155 | 4.52% |
| Redmile Group, LLC | 1,769,684 | $89,510,617 | 4.26% |
| Ghost Tree Capital, LLC | 250,000 | $12,645,000 | 4.16% |
| Logos Global Management LP | 600,000 | $30,348,000 | 4.05% |
| COMMODORE CAPITAL LP | 565,000 | $28,577,700 | 3.34% |
| Yiheng Capital Management, L.P. | 1,221,674 | $61,792,271 | 3.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $10,116,000 | 3.07% |
| Atlas Venture Life Science Advisors, LLC | 359,251 | $18,170,915 | 2.81% |
| Perceptive Advisors | 1,619,425 | $81,910,517 | 2.73% |